Clinical Trial Update: Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic/pharmacodynamic study of doripenem in febrile neutropenic patients completed; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia

Drugs mentioned

• Doripenem (Doripenem)

Snippet

Sponsor: Gary E. Stein, Pharm.D. | Conditions: Febrile Neutropenia | Phase 4 | Status: COMPLETED | Results posted: 2012-06-05